Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Marcio Versiani
JCP
Original Research
Long-Term Safety and Efficacy of Ziprasidone in Subpopulations of Patients With Bipolar Mania
June 17, 2009
Marcio Versiani
,
Lewis Warrington
,
Antony D. Loebel
, et al
JCP
Original Research
Reboxetine, a Selective Norepinephrine Reuptake Inhibitor, Is an Effective and Well-Tolerated Treatment for Panic Disorder
January 1, 2002
Marcio Versiani
,
Giovanni Cassano
,
Giulio Perugi
, et al
JCP
Original Research
Social Functioning in Depression: A Review.
September 30, 2000
Robert M. A. Hirschfeld
,
Stuart A. Montgomery
,
Martin B. Keller
, et al
JCP
Original Research
Reboxetine, a Unique Selective NRI, Prevents Relapse and Recurrence in Long-Term Treatment of Major Depressive Disorder
June 30, 1999
Marcio Versiani
,
Lembit Mehilane
,
Peter Gaszner
, et al
